Through
5/7
A round-up of Penn mentions in local, national, and international media.
Penn In the News
A study co-authored by Adriana Perez of the School of Nursing identifies four key barriers stopping Hispanic Americans who want to be vaccinated.
Penn In the News
A clinical trial at the Scheie Eye Institute in the Perelman School of Medicine finds that an experimental gene therapy can rapidly improve night vision in adults with a congenital form of childhood-onset blindness, featuring a quote from Artur Cideciyan.
Penn In the News
A new study from the Annenberg Public Policy Center finds that misinformation about vaccine safety is responsible for the dramatic discrepancy between child and adult vaccination rates, with a quote from Dan Romer.
Penn In the News
Rudra Sil and Kimberly St. Julian Varnon of the School of Arts & Sciences explain why surveys fearing a world war due to Russian provocation are no cause for panic.
Penn In the News
The Wharton School has contributed to the U.S. News & World Report 2022 Best Countries ranking, placing Switzerland at No.1 for the fifth time.
Penn In the News
An op-ed by Jason Karlawish of the Perelman School of Medicine is quoted encouraging a system of “whealthcare” that integrates monitoring and maintaining mental health and wealth, to foster older adults’ financial well-being.
Penn In the News
A study by Casey Halpern of the Perelman School of Medicine suggests that the impulse control associated with binge eating disorder stems from brain neurology, not a moral failing.
Penn In the News
Firoozeh Kashani-Sabet of the School of Arts & Sciences says that Iranian society still struggles with how much of a role religion has played in its pre- and post-revolutionary eras.
Penn In the News
Mark Neuman of the Perelman School of Medicine says that patients who received spinal anesthesia received fewer opioids in the operating room, but they ended up needing more prescription pain medication use after surgery.
Penn In the News
Drew Weissman of the Perelman School of Medicine spoke about future uses for the mRNA technology used to create the COVID-19 vaccines. Weissman and others are currently working on a potential universal flu vaccine.